Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy - 2000 - 2003
(2000; 81 pages) [French] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentAbbreviations, Acronyms & WHO Regions
View the documentHighlights - WHO Medicines Strategy: 2000 - 2003
Open this folder and view contents1. The Impact of Essential Drugs
Open this folder and view contents2. Strategic Directions
View the document3. Core Functions Improving Health Through Knowledge, Advocacy and Partnership
Open this folder and view contents4. Country Work - Why and How?
Open this folder and view contents5. Framework for Action: Objectives and Expected Outcomes for 2000 - 2003
Open this folder and view contents6. Monitoring Progress
View the documentReferences and Notes
 

WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy - 2000 - 2003

World Health Organization
Geneva, Switzerland

© World Health Organization 2000

This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, quoted, reproduced or translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.

The views expressed in documents by named authors are solely the responsibility of those authors.

The designations employed and the presentation of material on maps included in this document do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines represent approximate border lines for which there may not yet be full agreement.

Design & layout by L’IV Communications, Morges, Switzerland

WHO/EDM/2000.1
Original: English
Distribution: General

Prepared by:

Department of Essential Drugs and Medicines Policy,
Health Technology and Pharmaceuticals Cluster
WHO Headquarters, Geneva, Switzerland

Essential Drugs Programme, Regional Office for Africa

Program on Essential Drugs and Technology, Regional Office for the Americas

Essential Drugs and Biologicals, Regional Office for the Eastern Mediterranean

Pharmaceuticals Programme, Regional Office for Europe

Essential Drugs and Medicines Policy, Regional Office for South-East Asia

Pharmaceuticals Unit, Regional Office for the Western Pacific

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014